ReviewLung Cancer (Auckland, N.Z.)2015

Profile of ceritinib in the treatment of ALK+ metastatic non-small-cell lung cancer.

Mark W Burns et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.